Cipla inches higher by 1.26% as it reports resilient FY22 results

Cipla inches higher by 1.26% as it reports resilient FY22 results

by 5paisa Research Team Last Updated: May 11, 2022 - 05:44 pm 28.6k Views
Listen icon

The company witnessed a growth of 12.8% in revenues for FY22 

Cipla Ltd, an S&P BSE 100 company primarily engaged in manufacturing pharmaceuticals drugs, has been trending on Dalal Street as it has rallied by about 1.26% amid a falling market from its previous close of Rs 926.25. The scrip opened at Rs 890 and made a day’s high of Rs 942.50. 

The company announced its Q4 and FY22 results on 10th May. In Q4FY22, revenue grew by 13.94% YoY to Rs 5223.94 crore from Rs 4584.88 crore in Q4FY21. On a sequential basis, the top line was down by 4.02%. PBIDT (Ex OI) was reported at Rs 749.72 crore, down by 5.84% as compared to the year-ago period and the corresponding margin was reported at 14.25%, contracting by 304 basis points YoY. PAT was reported at Rs 376.72 crore, down by 9.34% from Rs 415.51 crore in the same quarter of the previous fiscal year. The PAT margin stood at 7.16% in Q4FY22 contracting from 9.02% in Q4FY21.

As far as the fiscal 2022 results are concerned, the revenues grew by 12.8% to Rs 21,623 crore as against FY21. The EBITDA and PAT increased by 7% and 6.5% to Rs 4,834 crore and Rs 2,559.5 crore, respectively. The stock witnessed a gap down of 3.88% but eventually recovered during the day.

Cipla Ltd focuses on the development of new formulations and has a wide range of pharmaceutical products. They offer prescription drugs, bulk drugs, animal products, pesticides, a wide range of food and beverages, baked foods, oral hygiene products, detergents, room fresheners and personal care products. The stock has a 52-week high of Rs 4,986.85 and a 52-week low of Rs 1,926.

Share Market Today


How do you rate this article?

Start Investing in 5 mins*

Rs. 20 Flat Per Order | 0% Brokerage

378X91-D3

About the Author

Our research team is composed of some highly qualified research professionals, their expertise range across sectors.


Enjoy 0%* Brokerage with 5paisa
Resend OTP
Please Enter OTP
Mobile No. belongs to

By proceeding, you agree to the T&C.

Latest News
Trust Fintech IPO Subscribed 108.63 times

Trust Fintech IPO is book-built issue of ₹63.45 crores, consisting entirely of fresh issue shares totalling 62.82 lakh. Trust Fintech IPO commenced its subscription period on March 26, 2024, & concludes today, March 28, 2024.

Aspire & Innovative IPO Subscribed 15.17 times

Aspire & Innovative IPO is a book built issue of Rs 21.97 crores. The issue comprises entirely a fresh issue of 40.68 lakh shares. Aspire & Innovative IPO opens for subscription on March 26, 2024, and closes on March 28, 2024. The allotment for the Aspire & Innovative IPO is expected to be finalized on Monday, April 1, 2024.

Blue Pebble IPO Subscribed 56.32 times

Blue Pebble IPO, valued at ₹18.14 crores, comprises fresh issue of 10.8 lakh shares. Commencing subscription on March 26, 2024, Blue Pebble IPO is set to conclude on March 28, 2024. Allotment process is scheduled to be finalized by Monday, April 1, 2024. Following this, IPO is slated to debut on NSE SME, with tentative listing date of Wednesday, April 3, 2024.